X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2653) 2653
Newsletter (355) 355
Publication (162) 162
Newspaper Article (31) 31
Book Review (28) 28
Magazine Article (24) 24
Book Chapter (9) 9
Dissertation (9) 9
Trade Publication Article (5) 5
Conference Proceeding (4) 4
Transcript (2) 2
Web Resource (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
tadalafil (2823) 2823
humans (1365) 1365
male (1292) 1292
index medicus (1098) 1098
erectile dysfunction (923) 923
sildenafil (887) 887
erectile dysfunction - drug therapy (694) 694
urology & nephrology (632) 632
middle aged (606) 606
sildenafil citrate (577) 577
impotence (555) 555
carbolines - therapeutic use (523) 523
vardenafil (469) 469
treatment outcome (430) 430
adult (415) 415
aged (383) 383
research (373) 373
phosphodiesterase inhibitors - therapeutic use (367) 367
men (353) 353
phosphodiesterase 5 inhibitors - therapeutic use (317) 317
pharmacology & pharmacy (311) 311
animals (306) 306
efficacy (298) 298
double-blind (289) 289
analysis (287) 287
care and treatment (277) 277
drug therapy (274) 274
vardenafil dihydrochloride (267) 267
carbolines - administration & dosage (247) 247
piperazines - therapeutic use (234) 234
female (230) 230
safety (230) 230
carbolines - pharmacology (223) 223
carbolines - adverse effects (222) 222
double-blind method (215) 215
sexual disorders (202) 202
dosage and administration (201) 201
pulmonary hypertension (195) 195
benign prostatic hyperplasia (193) 193
sulfones - therapeutic use (176) 176
phosphodiesterase inhibitors - adverse effects (171) 171
phosphodiesterase 5 inhibitors - administration & dosage (168) 168
rats (157) 157
hypertension, pulmonary - drug therapy (155) 155
phosphodiesterase 5 inhibitors (155) 155
chemistry, analytical (153) 153
nitric-oxide (152) 152
hypertension (151) 151
phosphodiesterase 5 inhibitors - pharmacology (151) 151
phosphodiesterase inhibitors - administration & dosage (150) 150
therapy (150) 150
phosphodiesterase inhibitors - pharmacology (148) 148
prostate (148) 148
erectile dysfunction - etiology (143) 143
imidazoles - therapeutic use (142) 142
clinical trials (136) 136
penile erection - drug effects (134) 134
purines (133) 133
purines - therapeutic use (132) 132
risk factors (131) 131
drugs (130) 130
urology (128) 128
dose-response relationship, drug (127) 127
pharmaceutical industry (126) 126
drug therapy, combination (125) 125
cyclic nucleotide phosphodiesterases, type 5 (123) 123
tadalafil - therapeutic use (121) 121
drug administration schedule (120) 120
inhibitors (120) 120
medical research (120) 120
patient satisfaction (120) 120
lower urinary tract symptoms (119) 119
nitric oxide (117) 117
phosphodiesterase 5 inhibitors - adverse effects (117) 117
vasodilator agents - therapeutic use (117) 117
hypertrophy (116) 116
triazines - therapeutic use (116) 116
health aspects (114) 114
cardiac & cardiovascular systems (113) 113
medicine, experimental (112) 112
time factors (110) 110
complications and side effects (109) 109
medicine & public health (108) 108
surveys and questionnaires (107) 107
phosphodiesterase type 5 inhibitors (105) 105
reports (103) 103
erectile dysfunction - physiopathology (101) 101
medicine, general & internal (101) 101
young adult (101) 101
pde5 inhibitors (100) 100
phosphodiesterase inhibitors (96) 96
international index (95) 95
piperazines - pharmacology (95) 95
pulmonary arterial hypertension (95) 95
mass spectrometry (92) 92
phosphodiesterase (92) 92
phosphodiesterase-5 inhibitors (91) 91
prevalence (90) 90
dietary supplements (89) 89
prostatic hyperplasia - drug therapy (88) 88
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2823) 2823
Chinese (57) 57
German (40) 40
French (37) 37
Spanish (36) 36
Russian (23) 23
Japanese (20) 20
Italian (5) 5
Korean (5) 5
Portuguese (5) 5
Turkish (5) 5
Czech (4) 4
Hungarian (4) 4
Polish (4) 4
Swedish (2) 2
Arabic (1) 1
Bosnian (1) 1
Croatian (1) 1
Dutch (1) 1
Finnish (1) 1
Hebrew (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Free Radical Biology and Medicine, ISSN 0891-5849, 07/2017, Volume 108, p. S60
The phosphodiesterases type 5 (PDE5) inhibitors (PDE5i) (e.g., sildenafil, tadalafil) widely used to treat erectile dysfunction, and for recreational purpose... 
Antioxidants | Tadalafil | Impotence
Journal Article
Biological and Pharmaceutical Bulletin, ISSN 0918-6158, 2017, Volume 40, Issue 8, pp. 1314 - 1319
Tadalafil and sildenafil are selective inhibitors of phosphodiesterase type 5, showing marked pharmacokinetic variability in patients with pulmonary arterial... 
Journal Article
The Journal of Sexual Medicine, ISSN 1743-6095, 08/2017, Volume 14, Issue 8, pp. 1018 - 1027
Journal Article
European Urology, ISSN 0302-2838, 08/2006, Volume 50, Issue 2, pp. 351 - 359
Background: Erectile dysfunction (ED) is a chronic disease; however, therapy is currently administered as needed with oral phosphodiesterase 5 (PDE5)... 
Tadalafil | Erectile dysfunction | Once-a-day dosing | once-a-day dosing | tadalafil | SILDENAFIL | TOLERABILITY | MEN | UROLOGY & NEPHROLOGY | DEMAND TADALAFIL | erectile dysfunction
Journal Article
European Journal of Pharmaceutical Sciences, ISSN 0928-0987, 01/2017, Volume 97, pp. 269 - 276
Journal Article
Acta Histochemica, ISSN 0065-1281, 05/2018, Volume 120, Issue 4, pp. 312 - 322
Journal Article
Biological and Pharmaceutical Bulletin, ISSN 0918-6158, 2019, Volume 42, Issue 1, pp. 110 - 115
The purpose of this study was to determine the serum protein binding of tadalafil in children with protein-losing enteropathy (PLE) and to evaluate the... 
Journal Article